Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Strengthens its Board of Directors

TORONTO, CANADA--(Marketwired - March 10, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
January 30, 2014 07:37 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman

TORONTO, ONTARIO--(Marketwired - Jan. 30, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
January 27, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Resignation of Director

TORONTO, ONTARIO--(Marketwired - Jan. 27, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
January 13, 2014 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Provides Corporate Update

TORONTO, ONTARIO--(Marketwired - Jan. 13, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
December 17, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Appoints Dr. Robert Kirkman to Its Board of Directors

TORONTO, ONTARIO--(Marketwired - Dec. 17, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
December 13, 2013 16:49 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Completes $33 Million Private Placement

TORONTO, ONTARIO--(Marketwired - Dec. 13, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell- related...
December 05, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics to Provide Update on CD47 Program at the 2013 Annual Meeting of the American Society of Hematology

TORONTO, ONTARIO--(Marketwired - Dec. 5, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
October 31, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia

TORONTO, ONTARIO--(Marketwired - Oct. 31, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
October 17, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of Complementary Antibody Program

TORONTO, ONTARIO--(Marketwired - Oct. 17, 2013) - Stem Cell Ther apeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical immuno-oncology company developing cancer stem...
September 17, 2013 07:00 ET | Source: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Adopts Shareholder Rights Plan

TORONTO, ONTARIO--(Marketwired - Sept. 17, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell-related...